TY - JOUR
T1 - Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation
AU - Fahmy, Lara M.
AU - Massie, Allan B.
AU - Muzaale, Abimereki D.
AU - Bagnasco, Serena M.
AU - Orandi, Babak J.
AU - Alejo, Jennifer L.
AU - Boyarsky, Brian J.
AU - Anjum, Saad K.
AU - Montgomery, Robert A.
AU - Dagher, Nabil N.
AU - Segev, Dorry L.
N1 - Funding Information:
This work was supported by grant numbers R01DK096008 and K24DK101828 from the National Institute of Diabetes and Digestive and Kidney Diseases
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Background Recent evidence suggests that living kidney donors are at an increased risk of end-stage renal disease. However, predicting which donors will have renal dysfunction remains challenging, particularly among those with no clinical evidence of disease at the time of donation. Although renal biopsies are not routinely performed as part of the donor evaluation process, they may yield valuable information that improves the ability to predict renal function in donors. Methods We used implantation protocol biopsies to evaluate the association between histological abnormalities in the donated kidney and postdonation renal function (estimated glomerular filtration rate, eGFR) of the remaining kidney in living kidney donors. Longitudinal analysis using mixed-effects linear regression was used to account for multiple eGFR measures per donor. Results Among 310 donors between 1997 and 2012, median (IQR) follow-up was 6.2 (2.5-8.7; maximum 14.0) years. In this cohort, the overall prevalence of histological abnormalities was 65.8% (19.7% abnormal glomerulosclerosis, 23.9% abnormal interstitial fibrosis and tubular atrophy (IFTA), 4.8% abnormal mesangial matrix increase, 32.0% abnormal arteriolar hyalinosis, and 32.9% abnormal vascular intimal thickening). IFTA was associated with a 5-mL/min/1.73 m2 decrease of postdonation eGFR after adjusting for donor age at donation, sex, race, preoperative systolic blood pressure, preoperative eGFR, and time since donation (P < 0.01). Conclusions In this single-center study, among healthy individuals cleared for living donation, IFTA was associated with decreased postdonation eGFR, whereas no other subclinical histological abnormalities provided additional information.
AB - Background Recent evidence suggests that living kidney donors are at an increased risk of end-stage renal disease. However, predicting which donors will have renal dysfunction remains challenging, particularly among those with no clinical evidence of disease at the time of donation. Although renal biopsies are not routinely performed as part of the donor evaluation process, they may yield valuable information that improves the ability to predict renal function in donors. Methods We used implantation protocol biopsies to evaluate the association between histological abnormalities in the donated kidney and postdonation renal function (estimated glomerular filtration rate, eGFR) of the remaining kidney in living kidney donors. Longitudinal analysis using mixed-effects linear regression was used to account for multiple eGFR measures per donor. Results Among 310 donors between 1997 and 2012, median (IQR) follow-up was 6.2 (2.5-8.7; maximum 14.0) years. In this cohort, the overall prevalence of histological abnormalities was 65.8% (19.7% abnormal glomerulosclerosis, 23.9% abnormal interstitial fibrosis and tubular atrophy (IFTA), 4.8% abnormal mesangial matrix increase, 32.0% abnormal arteriolar hyalinosis, and 32.9% abnormal vascular intimal thickening). IFTA was associated with a 5-mL/min/1.73 m2 decrease of postdonation eGFR after adjusting for donor age at donation, sex, race, preoperative systolic blood pressure, preoperative eGFR, and time since donation (P < 0.01). Conclusions In this single-center study, among healthy individuals cleared for living donation, IFTA was associated with decreased postdonation eGFR, whereas no other subclinical histological abnormalities provided additional information.
UR - http://www.scopus.com/inward/record.url?scp=84965034940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965034940&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000001236
DO - 10.1097/TP.0000000000001236
M3 - Article
C2 - 27152920
AN - SCOPUS:84965034940
SN - 0041-1337
VL - 100
SP - 1294
EP - 1298
JO - Transplantation
JF - Transplantation
IS - 6
ER -